• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Analgesics Market in the Netherlands to 2014 (OTC Healthcare) Product Image

Analgesics Market in the Netherlands to 2014 (OTC Healthcare)

  • Published: February 2011
  • Region: Netherlands, Holland
  • 27 pages
  • Datamonitor

Introduction

This databook provides key data and information on the Analgesics Market in the Netherlands (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The analgesics category was valued at €125.2m ($183.3m) in 2009, representing a CAGR of 2.8% since 2004.

By the end of 2014, the analgesics category will be worth €125.8m ($184.2m), with an expected CAGR of 0.1% between 2009 and 2014.

The analgesics market was led by paracetamol (representing 49% of the total value) followed by aspirin and other analgesics, with a 27.6% and 18.2% market share, respectively. Ibuprofen accounts for the remaining 5.2% share.

Bional Pharma B.V. READ MORE >



Chapter 1 Executive Summary
Summary category level: analgesics

Chapter 2 Definition

Chapter 3 Category Analysis: Analgesics
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 4 Macroeconomic Profile
Macroeconomic Indicators

Chapter 5 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research

LIST OF FIGURES
Figure 1: Analgesics, Netherlands, value by segment (€m), 2004-14
Figure 2: Analgesics, Netherlands, category growth comparison, by value, 2004-14
Figure 3: Analgesics, Netherlands, company share by value (%), 2008-09
Figure 4: Analgesics, Netherlands, distribution channels by value (%), 2008-09
Figure 5: Annual data review process

LIST OF TABLES
Table 1: Analgesics category definitions
Table 2: Analgesics distribution channels
Table 3: Analgesics, Netherlands, value by segment (€m), 2004-09
Table 4: Analgesics, Netherlands, value forecast by segment (€m), 2009-14
Table 5: Analgesics, Netherlands, value by segment ($m), 2004-09
Table 6: Analgesics, Netherlands, value forecast by segment ($m), 2009-14
Table 7: Analgesics, Netherlands, brand share by value (%), 2008-09
Table 8: Analgesics, Netherlands, value by brand (€m), 2008-09
Table 9: Analgesics, Netherlands, company share by value (%), 2008-09
Table 10: Analgesics, Netherlands, value by company (€m), 2008-09
Table 11: Analgesics, Netherlands, distribution channels by value (%), 2008-09
Table 12: Analgesics, Netherlands, value by distribution channel (€m), 2008-09
Table 13: Netherlands population, by age group, 2004-09 (millions)
Table 14: Netherlands population forecast, by age group, 2009-14 (millions)
Table 15: Netherlands population, by gender, 2004-09 (millions)
Table 16: Netherlands population forecast, by gender, 2009-14 (millions)
Table 17: Netherlands nominal GDP, 2004-09 (€bn, nominal prices)
Table 18: Netherlands nominal GDP forecast, 2009-14 (€bn, nominal prices)
Table 19: Netherlands real GDP, 2004-09 (€bn, 2000 prices)
Table 20: Netherlands real GDP forecast, 2009-14 (€bn, 2000 prices)
Table 21: Netherlands real GDP, 2004-09 ($bn, 2000 prices)
Table 22: Netherlands real GDP forecast, 2009-14 ($bn, 2000 prices)
Table 23: Netherlands consumer price index, 2004-09 (2000=100)
Table 24: Netherlands consumer price index, 2009-14 (2000=100)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos